由ChAdOx1-S和BNT162b2COVID-19疫苗诱导的不同异质免疫效应
Elisabeth A Dulfer1, Büsra Geckin1, Martijn Zoodsma2
1Radboud community for infectious diseases, department of internal medicine, Radboud university medical center, 6500, HB, Nijmegen, the Netherlands.
Cellular immunology
|October 28, 2025
概括
基于腺病毒的COVID-19疫苗比mRNA疫苗诱导了更高的促炎细胞因子反应. 这些差异在mRNA增强剂后减少,这表明有明显的免疫效应影响非COVID健康结果.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 分子生物学分子生物学
背景情况:
- 包括mRNA和腺病毒载体平台在内的COVID-19疫苗可能对非COVID发病率产生差异性的异质效应.
- 研究潜在的免疫机制对于理解这些疫苗诱导的差异至关重要.
研究的目的:
- 为了比较接种了腺病毒载体 (ChAdOx1-S) 和mRNA (BNT162b2) COVID-19疫苗的个体之间的免疫反应.
- 为了探索这些免疫差异如何在BNT162b2 mRNA增强疫苗接种后演变.
主要方法:
- 在外周血液单核细胞 (PBMCs) 中分析转录活性,细胞类型分布和细胞因子分泌.
- 最初用ChAdOx1-S接种疫苗的参与者与BNT162b2.2.之间的比较.
- 在接种BNT162b2增剂疫苗后评估免疫变化.
主要成果:
- 在腺病毒和mRNA疫苗组之间,在刺激后发现了84个差异表达的基因组.
- 与mRNA疫苗接种者相比,用腺病毒载体接种疫苗的个体表现出持续较高的促炎细胞因子反应.
- 在接种mRNA增剂疫苗后,这些独特的细胞因子概况减弱了.
结论:
- 这些发现支持了基于腺病毒和mRNA疫苗具有明显的免疫效应的假设.
- 与腺病毒疫苗接种相关的较高的促炎性细胞因子反应可能解释了异种疫苗效应的观察差异.
- 了解这些非特异性影响 (NSE) 对公共卫生政策至关重要,特别是对弱势群体.
相关概念视频
Cross-reactivity
32.8K
Overview
32.8K
B Cell Activation and Differentiation
15.9K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.9K
Vaccinations
51.2K
Overview
51.2K
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
Diversity of Antigen Receptors
1.4K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.4K
Humoral Immune Responses
83.3K
Overview
83.3K


